Avastin
Keytruda: Merckās breakthrough cancer drug with mixed results at ESMO
Anika Sharma
Merck & Co. made significant strides at this year’s European Society for Medical Oncology (ESMO) congress, presenting a series of ...
Outlookās eye drug Lytenava fails to win FDA approval, despite positive trial
Anika Sharma
Outlook Therapeutics has been working on a reformulated version of Rocheās cancer drug Avastin for the treatment of certain eye ...